The sale has been hampered by differences over price and the challenging vitamins part of the business, with both buyout firms pushing DSM to separate that unit from the disposal, said the people, who asked not to be identified because discussions are private.
Amsterdam-listed DSM-Firmenich would prefer to sell the entire business in one swoop, but bidders’ concerns around the vitamins part, which ...